Historical shareholding details of Fidelity MSCI Health Care ETF holdings in 4D Molecular Therapeutics Inc (FDMT)

Monthly changes of Fidelity MSCI Health Care ETF shareholding in 4D Molecular Therapeutics Inc over the previous months

Month Name Total no. shares held Percent Holding
Feb 28, 2025 Fidelity Msci Health Care Etf 11,373 0.02%
Feb 27, 2025 Fidelity Msci Health Care Etf 11,373 0.02%
Jan 31, 2025 Fidelity Msci Health Care Etf 11,261 0.02%
Jan 30, 2025 Fidelity Msci Health Care Etf 11,275 0.02%
Dec 31, 2024 Fidelity Msci Health Care Etf 11,331 0.02%
Dec 28, 2024 Fidelity Msci Health Care Etf 11,331 0.02%
Nov 30, 2024 Fidelity Msci Health Care Etf 11,429 0.02%
Nov 28, 2024 Fidelity Msci Health Care Etf 11,429 0.02%
Oct 31, 2024 Fidelity Msci Health Care Etf 11,527 0.02%
Oct 18, 2024 Fidelity Msci Health Care Etf 11,513 0.02%
Sep 28, 2024 Fidelity Msci Health Care Etf 11,611 0.02%
Sep 27, 2024 Fidelity Msci Health Care Etf 11,611 0.02%
Aug 31, 2024 Fidelity Msci Health Care Etf 14,019 0.03%
Aug 30, 2024 Fidelity Msci Health Care Etf 14,019 0.03%
Jul 31, 2024 Fidelity Msci Health Care Etf 14,067 0.03%
Jul 30, 2024 Fidelity Msci Health Care Etf 14,067 0.03%
Jun 29, 2024 Fidelity Msci Health Care Etf 14,419 0.03%
Jun 28, 2024 Fidelity Msci Health Care Etf 14,419 0.03%
May 30, 2024 Fidelity Msci Health Care Etf 13,255 0.03%
Apr 27, 2024 Fidelity Msci Health Care Etf 13,435 0.03%
Mar 29, 2024 Fidelity Msci Health Care Etf 13,930 0.03%
Feb 29, 2024 Fidelity Msci Health Care Etf 13,945 0.03%
Jan 31, 2024 Fidelity Msci Health Care Etf 10,808 0.03%
Dec 28, 2023 Fidelity® Msci Health Care Etf 10,786 0.03%
Nov 30, 2023 Fidelity® Msci Health Care Etf 10,845 0.03%
Oct 28, 2023 Fidelity® Msci Health Care Etf 11,011 0.03%
Sep 29, 2023 Fidelity® Msci Health Care Etf 11,131 0.03%
Aug 30, 2023 Fidelity® Msci Health Care Etf 15,090 0.04%
Jul 29, 2023 Fidelity® Msci Health Care Etf 15,090 0.04%
Jun 23, 2023 Fidelity® Msci Health Care Etf 14,802 0.04%
May 30, 2023 Fidelity® Msci Health Care Etf 0 0.00%

View all ownership details of 4D Molecular Therapeutics Inc